Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest - 16/12/20

Dimitrios Patoulias, MD ^{a, ⁎} , Christodoulos Papadopoulos, MD, PhD ^b, Alexandra Katsimardou, MD ^a, Michael Doumas, MD, PhD ^{a, c}

^a Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece 

^b Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece 

^c Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia 

^⁎Corresponding author: Tel: +30-6946900777; fax: +30-2310225083.

Le texte complet de cet article est disponible en PDF.